Detailed information for compound 1007722

Basic information

Technical information
  • TDR Targets ID: 1007722
  • Name: 2-methoxy-3,5-dimethyl-6-[(1R,2'R,6S,7S,8R)-1 ,3,5-trimethyl-8-(4-nitrophenyl)spiro[bicyclo [4.2.0]octa-2,4-diene-7,4'-oxolane]-2'-yl]pyr an-4-one
  • MW: 477.549 | Formula: C28H31NO6
  • H donors: 0 H acceptors: 3 LogP: 4.25 Rotable bonds: 4
    Rule of 5 violations (Lipinski): 1
  • SMILES: COc1oc([C@@H]2OC[C@@]3(C2)[C@H]2C(=CC(=C[C@]2([C@H]3c2ccc(cc2)[N+](=O)[O-])C)C)C)c(c(=O)c1C)C
  • InChi: 1S/C28H31NO6/c1-15-11-16(2)24-27(5,12-15)25(19-7-9-20(10-8-19)29(31)32)28(24)13-21(34-14-28)23-17(3)22(30)18(4)26(33-6)35-23/h7-12,21,24-25H,13-14H2,1-6H3/t21-,24+,25-,27-,28+/m1/s1
  • InChiKey: DXCYJJKWPZZHNZ-PAWAVCGOSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

  • 2-methoxy-3,5-dimethyl-6-[(1R,2'R,6S,7S,8R)-1,3,5-trimethyl-8-(4-nitrophenyl)spiro[bicyclo[4.2.0]octa-2,4-diene-7,4'-tetrahydrofuran]-2'-yl]pyran-4-one
  • 2-methoxy-3,5-dimethyl-6-[(1R,2'R,6S,7S,8R)-1,3,5-trimethyl-8-(4-nitrophenyl)-2'-spiro[bicyclo[4.2.0]octa-2,4-diene-7,4'-tetrahydrofuran]yl]-4-pyranone

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Mycobacterium tuberculosis Probable isocitrate lyase AceAb [second part] (isocitrase) (isocitratase) (Icl) 0.1694 1 1
Onchocerca volvulus 0.0036 0 0.5
Trypanosoma cruzi hypothetical protein, conserved 0.0036 0 0.5
Brugia malayi Calcitonin receptor-like protein seb-1 0.0049 0.0083 0.0196
Trypanosoma cruzi hypothetical protein, conserved 0.0036 0 0.5
Trichomonas vaginalis esterase, putative 0.0036 0 0.5
Schistosoma mansoni protein tyrosine phosphatase non-receptor type nt1 0.0736 0.422 1
Trichomonas vaginalis penicillin-binding protein, putative 0.0036 0 0.5
Mycobacterium tuberculosis Probable isocitrate lyase AceAa [first part] (isocitrase) (isocitratase) (Icl) 0.1694 1 1
Onchocerca volvulus 0.0036 0 0.5
Trichomonas vaginalis D-aminoacylase, putative 0.0036 0 0.5
Echinococcus granulosus tyrosine protein phosphatase non receptor type 0.0736 0.422 1
Trichomonas vaginalis D-aminoacylase, putative 0.0036 0 0.5
Mycobacterium ulcerans isocitrate lyase Icl 0.1694 1 1
Trichomonas vaginalis D-aminoacylase, putative 0.0036 0 0.5
Mycobacterium leprae Isocitrate lyase 0.0794 0.4573 0.4573
Trichomonas vaginalis penicillin-binding protein, putative 0.0036 0 0.5
Loa Loa (eye worm) hypothetical protein 0.0049 0.0083 0.0196
Trypanosoma brucei hypothetical protein, conserved 0.0036 0 0.5
Mycobacterium tuberculosis Isocitrate lyase Icl (isocitrase) (isocitratase) 0.1694 1 1
Onchocerca volvulus 0.0036 0 0.5
Loa Loa (eye worm) protein-tyrosine phosphatase 0.0736 0.422 1
Brugia malayi Protein-tyrosine phosphatase containing protein 0.0736 0.422 1
Leishmania major hypothetical protein, conserved 0.0036 0 0.5
Echinococcus multilocularis tyrosine protein phosphatase non receptor type 0.0736 0.422 1
Mycobacterium tuberculosis Possible penicillin-binding protein 0.0228 0.1159 0.1159
Plasmodium vivax hypothetical protein, conserved 0.0036 0 0.5
Toxoplasma gondii ABC1 family protein 0.0036 0 0.5
Loa Loa (eye worm) pigment dispersing factor receptor c 0.0049 0.0083 0.0196
Brugia malayi Corticotropin releasing factor receptor 2 precursor, putative 0.0049 0.0083 0.0196
Mycobacterium ulcerans isocitrate lyase AceAb 0.1694 1 1

Activities

No activities found for this compound.

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.